Error loading player: No playable sources found

AM24-MN-29-O

AM24-MN-29-O: Innovation in Transfusion: How Creative Partnerships are Improving the Care of Critically Ill Trauma Patients (Enduring)

Date
October 23, 2024
Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

As the concept of pre-hospital transfusion for trauma rapidly gains traction in the US, the essential role of blood bank leaders in developing these complex programs becomes ever more clear. Effective EMS blood programs require creativity and cooperation between many essential stakeholders, including hospitals, blood banks, trauma and EMS leaders, local government authorities, and industry partners. This presentation will bring together innovators from these disciplines who have each been involved in the creation of a diverse range of prehospital blood programs and have subsequently partnered in the development of regional and national collaboratives, educational initiatives, and trauma outcomes research. This session we will emphasize the opportunities to improve patient care and save lives, the wide range of challenges encountered in developing effective pre-hospital transfusion programs, and strategies to overcome these many barriers faced along the way. Throughout we will emphasize the essential role of blood bank leaders as key catalysts in the development of effective programs. This educational session will provide an overview of the current state of pre-hospital transfusion in the US, including an up-to-date survey of active EMS blood programs, the status of multiple regional, state-wide, and national collaboratives, and evolving policy updates from national organizations. More detailed descriptions of at least two active programs will be provided, contrasting the fascinating similarities and differences between fast-paced urban EMS programs and rural agencies and highlighting the unique challenges and opportunities faced by each. We will also provide a review of the recent literature on the impact of trauma outcomes, much of which has emerged from these agencies. After brief presentations by each of 5 participants, a panel discussion with audience participation will address controversies and questions in the creation and growth of successful pre-hospital transfusion programs.

Learning Objectives

  • After attending this session, the audience will be able to describe the prevalence of prehospital transfusion programs in the US
  • After attending this session, the audience will be able to discuss the research evidence supporting EMS transfusion programs
  • After attending this session, the audience will be able to identify opportunities for blood banks to play a leadership role in the development of successful programs
  • After attending this session, the audience will be able to identify and help organize the key stakeholders required to develop a successful program

Moderator

Speaker Image for Randi Schaefer
Randi Schaefer, DNP, RN, ACNS-BC, CEN
Schaefer Consulting

Speakers

Speaker Image for Warren Christina
Warren Christina, MSHS,MLS(ASCP)SBB
Atrium Health Wake Forest Baptist
Speaker Image for Tom Dransfield
New Orleans EMS
Speaker Image for Mark Piehl
Mark Piehl, MD, MPH
University of North Carolina (UNC) School of Medicine

Related Products

Thumbnail for AM24-SN-02-O: New Directions in Coagulation Management and Transfusion Practice with Viscoelastic Testing in the OR (Enduring)
AM24-SN-02-O: New Directions in Coagulation Management and Transfusion Practice with Viscoelastic Testing in the OR (Enduring)
Anesthetic and surgical techniques have greatly improved blood loss outcomes in patients undergoing surgery, especially in heart and liver transplantation, but substantial blood use and critical decision points remain…
Thumbnail for AM24-MN-03-O: Clinical Relevance of ABO Antibodies and the New Era of Lectin Array Analysis of RBC ABO Glycosylation (Enduring)
AM24-MN-03-O: Clinical Relevance of ABO Antibodies and the New Era of Lectin Array Analysis of RBC ABO Glycosylation (Enduring)
Minor ABO-incompatible transfusion of plasma containing products has been a necessary and common practice in transfusion medicine…
Thumbnail for AM24-MN-37-O: Hemorrhage Control and Resuscitation: New Tools (Enduring)
AM24-MN-37-O: Hemorrhage Control and Resuscitation: New Tools (Enduring)
Saving lives of severely injured individuals requires 1) control of hemorrhage and 2) resuscitation. Lack of people or materials to carry out these activities means that individuals injured in rural and remote areas have high mortality rates…
Thumbnail for AM24-MN-12-O: Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster (Enduring)
AM24-MN-12-O: Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster (Enduring)
Many hospitals have administrative and clinical elements for Mass Casualty Events (MCE) but often do not include how to determine the number of blood products that will be needed and rarely how the products will be distributed or tracked…